Citigroup’s Biohaven Pharmaceutical Holding Company Ltd. BHVN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-361,076
| Closed | -$54.6M | – | 5403 |
|
|
2022
Q3 | $54.6M | Buy |
361,076
+315,276
| +688% | +$47.7M | 0.04% | 247 |
|
|
2022
Q2 | $6.67M | Buy |
45,800
+28,790
| +169% | +$4.2M | 0.01% | 984 |
|
|
2022
Q1 | $2.02M | Sell |
17,010
-47,425
| -74% | -$5.62M | ﹤0.01% | 1766 |
|
|
2021
Q4 | $8.88M | Buy |
64,435
+5,822
| +10% | +$802K | ﹤0.01% | 983 |
|
|
2021
Q3 | $8.14M | Buy |
58,613
+10,717
| +22% | +$1.49M | ﹤0.01% | 1070 |
|
|
2021
Q2 | $4.65M | Sell |
47,896
-19,267
| -29% | -$1.87M | ﹤0.01% | 1472 |
|
|
2021
Q1 | $4.59M | Buy |
67,163
+52,320
| +352% | +$3.58M | ﹤0.01% | 1387 |
|
|
2020
Q4 | $1.27M | Buy |
14,843
+8,580
| +137% | +$736K | ﹤0.01% | 2004 |
|
|
2020
Q3 | $407K | Sell |
6,263
-29,062
| -82% | -$1.89M | ﹤0.01% | 2369 |
|
|
2020
Q2 | $2.58M | Sell |
35,325
-2,390
| -6% | -$175K | ﹤0.01% | 1439 |
|
|
2020
Q1 | $1.28M | Buy |
37,715
+24,546
| +186% | +$835K | ﹤0.01% | 1643 |
|
|
2019
Q4 | $717K | Sell |
13,169
-7,804
| -37% | -$425K | ﹤0.01% | 2408 |
|
|
2019
Q3 | $875K | Sell |
20,973
-45,325
| -68% | -$1.89M | ﹤0.01% | 2216 |
|
|
2019
Q2 | $2.9M | Buy |
66,298
+59,882
| +933% | +$2.62M | ﹤0.01% | 1381 |
|
|
2019
Q1 | $330K | Sell |
6,416
-86,445
| -93% | -$4.45M | ﹤0.01% | 2791 |
|
|
2018
Q4 | $3.43M | Buy |
92,861
+26,019
| +39% | +$962K | ﹤0.01% | 1227 |
|
|
2018
Q3 | $2.51M | Buy |
66,842
+29,436
| +79% | +$1.11M | ﹤0.01% | 1373 |
|
|
2018
Q2 | $1.48M | Buy |
37,406
+37,244
| +22,990% | +$1.47M | ﹤0.01% | 1645 |
|
|
2018
Q1 | $4K | Sell |
162
-6
| -4% | -$148 | ﹤0.01% | 4681 |
|
|
2017
Q4 | $5K | Buy |
+168
| New | +$5K | ﹤0.01% | 4689 |
|
|
2017
Q3 | – | Sell |
-67
| Closed | -$2K | – | 5129 |
|
|
2017
Q2 | $2K | Buy |
+67
| New | +$2K | ﹤0.01% | 4654 |
|